0 avis
Effective Management of 177Lu-DOTA0-Tyr3-Octreotate Extravasation
Archive ouverte
Edité par CCSD ; Lippincott, Williams & Wilkins -
International audience. Radiopharmaceutical extravasation is a known nuclear medicine adverse effect, mostly with no complication in case of diagnostic radiopharmaceutical. However, a therapeutic radiopharmaceutical extravasation may have clinical consequences and must be treated quickly and effectively. We report here a case of 177Lu-DOTA0-Tyr3-octreotate extravasation.